Migraine Pain Relief.

The article focuses on a new group of drugs that are helping people fight migraine in the U.S. It is mentioned that Erenumab was one of four monoclonal antibodies, which have been approved by the U.S. Food and Drug Administration to prevent migraine. It presents the views of neurologist David Dodick of the Mayo Clinic in Phoenix, who stated that nearly half of people who took one of the four drugs in clinical trials witnessed at least a 50 percent reduction in monthly migraines.